Literature DB >> 9163602

Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.

T Sato1, C Selleri, S Anderson, N S Young, J P Maciejewski.   

Abstract

Interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and Fas-ligand can mediate potent inhibitory signals in haemopoietic cells. Clinical and laboratory studies have suggested the involvement of these cytokines in the regulation of normal haemopoiesis and in the pathophysiology of bone marrow (BM) failure syndromes. As the effects of cytokines may also be regulated at the cellular receptor level, we studied the expression and modulation of TNF receptor (TNFR), IFN-gammaR and Fas-R on haemopoietic progenitor cells. In freshly isolated BM, using flow cytometry, TNFR1 (p55), TNFR2 (p75), IFN-gammaR, and Fas-R were detected on 5-12% of mononuclear cells. Two-colour staining showed comparable receptor expression on a CD34+ population, which includes haemopoietic progenitor and stem cells. Using reverse transcriptase-PCR (RT-PCR) transcription of mRNA coding for these receptors was demonstrated in fresh, highly purified CD34+ cells. These findings indicate that the effects of these factors on progenitor cells may be directly mediated. In cultured BM cells, expression of TNFR1 was not influenced by IFN-gamma, TNF-alpha or apoptosis-inducing anti-Fas monoclonal antibody (mAb). IFN-gamma decreased CD34+ cell TNFR2 expression. CD34+ cell Fas-R expression was increased by IFN-gamma and TNF-alpha. IFN-gammaR expression was enhanced by anti-Fas mAb and to lesser degree with TNF-alpha. Similar results were obtained with RT-PCR analysis in cultured CD34+ cells. Potentiation of anti-Fas mAb-mediated inhibition of haemopoietic colony formation by IFN-gamma and TNF-alpha was observed. Similarly, anti-Fas mAb enhanced the inhibitory effects of IFN-gamma. These results suggest that, in addition to interacting at the level of intracellular signalling pathways, IFN-gamma, TNF-alpha or Fas-ligand may potentiate or antagonize their effects through modulation of cytokine receptor expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163602     DOI: 10.1046/j.1365-2141.1997.562704.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Immune-mediated aplastic anaemia.

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2005-11       Impact factor: 3.183

2.  T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.

Authors:  Elaine M Sloand; J Joseph Melenhorst; Zachary C G Tucker; Loretta Pfannes; Jason M Brenchley; Agnes Yong; Valeria Visconte; Colin Wu; Emma Gostick; Phillip Scheinberg; Matthew J Olnes; Daniel C Douek; David A Price; A John Barrett; Neal S Young
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

3.  Activation and crosstalk between TNF family receptors in umbilical cord blood cells is not responsible for loss of engraftment capacity following culture.

Authors:  Keren Mizrahi; Nadir Askenasy
Journal:  Am J Stem Cells       Date:  2013-12-22

4.  Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.

Authors:  Sandhya R Panch; Yu Ying Yau; Elizabeth M Kang; Suk See De Ravin; Harry L Malech; Susan F Leitman
Journal:  Transfusion       Date:  2014-08-21       Impact factor: 3.157

5.  Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.

Authors:  C Fabris; M Del Forno; E Falleti; P Toniutto; M Pirisi
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.

Authors:  Elaine M Sloand; Loretta Pfannes; Gubin Chen; Simant Shah; Elena E Solomou; John Barrett; Neal S Young
Journal:  Blood       Date:  2006-11-07       Impact factor: 22.113

Review 7.  IKK{beta} as a target for treatment of inflammation induced bone loss.

Authors:  M G Ruocco; M Karin
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

8.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

9.  Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation.

Authors:  Vitalyi Senyuk; Pritesh Patel; Nadim Mahmud; Damiano Rondelli
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

10.  The hematologic response to anti-apoptotic cytokine therapy: results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome.

Authors:  Min Kyoung Kim; Jae Lyun Lee; Hee Soon Cho; Sung Hwa Bae; Hun Mo Ryoo; Kyung Hee Lee; Myung Soo Hyun
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.